Javier Martin-Broto, Sarcoma Medical Oncologist at the University Hospital Fundacion Jimenez Diaz, shared a post on LinkedIn about an article he and his colleagues authored:
“We are very pleased with the recent publication of this study aimed at assessing discrepancies in the histological diagnosis of sarcomas across various centers in Latin America, reviewed by a transatlantic team of expert pathologists. Clearly, histological diagnosis poses challenges in sarcomas and requires a high level of expertise. Without proper diagnosis and a multidisciplinary team, it’s difficult to outline an effective treatment plan. I want to express my gratitude to the entire team of pathologists for their tremendous efforts.
Special thanks to Alberto Rigui, Marco Gambarotti, David Moura, and Paolo dei Tos for their generous contributions to this study and for their diagnostic support over the years to sarcoma patients in Latin America. I am confident that this inspiring effort will continue to motivate us as we strive to conquer challenges and make meaningful changes in our field.”
Title: Histopathologic Diagnostic Agreement Study in Bone and Soft Tissue Tumors: The SELNET Sarcoma Network Experience
Authors: Alberto Righi, Marco Gambarotti, Rafael Ramos, Rodolfo Guzman, Carmen Nieves Hernandez-Leon, Cleo Romagosa, Jose Merino, Sandro Casavilca, Victor Castro, Juan Carlos Haro, Maria Luisa Cabañas, Maria Lucila Gonzalez, Felipe Costa, Fernando Campos, Ronald Limon, Edith Claros Mercado, Lucia Gonzalez, Matias Chacon, Marina Pacheco, Gema Aguil, Maurizio Donato Acuña, Natalia Jimenez, Ronald Badilla, Gabriela Chaves Quesada, Gisela German, Teresa Fili, Felipe Buscaglia, Nicolas Devaud, Luis Matamala, Haydee Caro, Jean-Yves Blay, Paola Collini, Salvatore Provenzano, Nadia Hindi, Antonio Gutierrez, Bruna Bianca Lopes David, David S. Moura, Marta Sbaraglia, Javier Martin-Broto, Angelo Paolo Dei Tos
More posts featuring Javier Martin-Broto on OncoDaily.